Pharmaceutical Industry Fellowship Programs

The St. John’s University College of Pharmacy and Health Sciences offers both one and two-year post Pharm. D. fellowship programs designed to train the Doctor of Pharmacy graduate in specific practice areas of the pharmaceutical industry. The College is currently partnering with four Pharmaceutical Industry Leaders: Allergan, an AbbVie Company, American Regent, Daiichi Sankyo and Pfizer.

In addition to their responsibilities at our program partners, the fellows will have opportunities to engage in teaching and research activities at St. John’s University.

In the 2021-2023 cycle, two programs will be recruiting for new fellows (one position each) in the following areas:

American Regent

      Medical Affairs

Pfizer Inc

      Health Economics and Outcomes Research (HEOR)/Market  Access


For the 2021-2023 fellowship cycle, Allergan, an AbbVie Company, will not be recruiting fellows for 2021 positions.

Effective July 2021, Daiichi Sankyo Inc. (DSI)  is committed to the investment and growth in our PharmD Fellowship program community and has had and will continue to have a strong partnership with St. John's University.  However, due to the company's business needs, growth of program, and focused therapeutic areas - DSI has made the decision to recruit any future PharmD Fellowship opportunities through Rutgers University moving forward”

Several new potential affiliations are in development and may be announced shortly.

The application process for the 2021-2023 fellowship cycle will be as follows:

To be considered for an initial interview applicants must e-mail their Curriculum Vitae and Letter of Intent from October 19, 2020 until November 13, 2020 to William Maidhof, Pharm.D. Dr. Maidhof serves as the Fellowship Program Coordinator for both American Regent and Pfizer, and his e-mail is [email protected] Recruitment will occur virtually and will NOT be conducted through the Personnel Placement Service (PPS) at the 2020 ASHP Midyear Clinical Meetings. 

Application material Deadlines are outlined below:

Required Item 

Deadline

Curriculum Vitae

November 13, 2020

Letter of Intent

November 13, 2020

Official College Transcript

November 20, 2020

Three Letters of Recommendation 

November 20, 2020

PROGRAM LEADERSHIP

Professional head shot of William Maidof, standing in front of a tan background, wearing a navy blue blazer, white shirt and royal blue tie. He has his arms crossed and is smiling.

William Maidof, Pharm. D.
Program Coordinator - American Regent, Inc/Pfizer, Inc. Fellowship
 
Associate Professor-Industry Professional
[email protected] 

Professional head shot of Maha Saad. She is standing in front of St. Thomas Moore church on a cloudy day. Her arms are crossed in front of her. She is wearing a navy blue blazer, light blue blouse. She is smiling.

Maha Saad, Pharm.D., BCGP, BCPS 
Program Coordinator- Daiichi Sankyo Fellowship 

Associate Clinical Professor 
[email protected] 

Professional head shot of Joseph Brocavich, standing in front of a blue background, wearing a blue blazer, teal collared shirt, and multi-colored tie. He wears glasses, has salt and pepper hair, and is smiling.

Joseph Brocavich, PharmD
Senior Associate Dean for Pharmacy 

Associate Clinical Professor
College of Pharmacy and Health Sciences
St John’s University
8000 Utopia Parkway
Queens, NY 11439
[email protected]

Additional Information

St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellowship—Global Regulatory Strategy

Kendra headshot

Kendra Croker, Pharm.D., is the 2019–21 St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellow in Global Regulatory Strategy and serves as this year’s chief fellow. She obtained her Doctor of Pharmacy degree from Wilkes University’s Nesbitt School of Pharmacy in Wilkes Barre, PA. During her time at Wilkes University, Dr. Croker served as tutoring chair for the American Pharmacists Association and social media coordinator for the Opioid Epidemic Committee, and was a member of the Over-The-Counter Competition team for the Pennsylvania Pharmacists Association.

As a member of the Wilkes University Women’s Tennis team, Dr. Croker was awarded Middle Atlantic Conference (MAC) Rookie of the Year, MAC Player of the Year, and MAC Scholar Athlete of the Year, and earned eight MAC tournament medals. Kendra completed a rotation in Regulatory Affairs at CVS corporate and a rotation in Pharmacovigilance at Sanofi Pasteur.

She is excited to use her past experiences to help bring medications to market for patients around the globe. In her free time, she enjoys traveling and spending time with family and friends.

Lillian Justus Headshot

Lillian Justus, Pharm.D., is the 2020-21 St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellow in Global Regulatory Strategy. She received her Doctor of Pharmacy degree at Ohio Northern University’s Raabe College of Pharmacy in Ada, OH.

During her time at Ohio Northern University, Dr. Justus held several leadership positions, as well as participated as an active member in a variety of organizations, including Mortar Board, the Rho Chi Society, Student Society of the American Society of Health-System Pharmacists, and Phi Lambda Sigma. She is excited to contribute to patient care on a global level by helping bring new and innovative medications to market. In her free time, she enjoys traveling, reading, and spending quality time with her family and friends. 

St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellowship—Clinical Development

Shirley Chung Headshot

Shirley Chung ’20Pharm.D., is the 2020–21 St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellow in Clinical Development. She received her Doctor of Pharmacy degree from St. John’s University’s College of Pharmacy and Health Sciences.

During her time at St. John’s, Dr. Chung served as an active leader through her executive board positions for the Rho Chi Society, College of Psychiatric and Neurologic Pharmacists, American Society of Consultant Pharmacists, and Lambda Kappa Sigma Fraternity. She is passionate about filling gaps in health care, and is thrilled for this opportunity to learn from the great multidisciplinary team at Allergan, an AbbVie Company and grow her passion specifically in Clinical Development.

Dr. Chung always makes it a point to challenge herself and try new things like cliff diving and (attempt at) cooking. She enjoys providing mentorship to others, and indulging in desserts—especially decadent lemon tarts.

Picture of Simranpreet Waraich outside in a coat, with blue sky and palm trees in the background.

Simranpreet Waraich ’19Pharm.D., is the 2019–21 St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellow in Clinical Development. She received her Doctor of Pharmacy degree from St. John’s University’s College of Pharmacy and Health Sciences.

During her time at St. John’s, Dr. Waraich served on the executive boards of APhA Academy of Student Pharmacists, the Academy of Managed Care Pharmacy, Lambda Kappa Sigma, and the Rho Chi Society. Dr. Waraich is interested in the drug development process and is passionate about impacting patients globally. She enjoys traveling, reading, and volunteering in her spare time.

St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellowship—Regulatory Affairs/Advertising and Labeling

Kim Do Headshot

Kim Do ’19Pharm.D., is the 2020–21 St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellow in Regulatory Affairs/Advertising and Labeling. She received her Doctor of Pharmacy degree from St. John’s University’s College of Pharmacy and Health Sciences.

During her time at St. John’s, Dr. Do was an advocate for social justice, health equity, and cultural awareness. She was passionate about organizing and participating in service events that promoted these values. Postgraduation, Kim worked in specialty pharmacy, with a specific focus in pediatrics. She is excited to utilize her unique skillset and past experiences to make a global impact through pharmaceutical industry. In her free time, she enjoys traveling, reading, and relaxing at the beach.

Photo of Ann Lee in front of a large window that overlooks a lawn and some trees.

Ann Lee, Pharm.D., is the 2019–21  St. John’s University/Allergan, an AbbVie Company, Pharmaceutical Industry Fellow in Regulatory Affairs/Advertising and Labeling. She has committed herself to being an active member of her community and pursuing leadership in everything she does. Dr. Lee also dedicates her time to participating in service mission trips abroad and other community service opportunities.

Dr. Lee has always been interested in policy and procedure and how this can be better utilized to help the community and society. She enjoys spending time reading exciting news in the industry and inspiring books—and being outside to rest and recharge!

St. John’s University/American Regent Pharmaceutical Industry Fellowship—Medical Affairs

Emily Hyunh

Emily Huynh, Pharm.D., is the 2020–22 St. John’s University/American Regent Industry Fellow in Medical Affairs. Dr. Huynh received her Doctor of Pharmacy degree from Philadelphia College of Pharmacy (PCP).

During her final year of pharmacy school, she completed a pharmaceutical industry rotation in Medical Affairs. She created a presentation that discussed a medication, currently undergoing Phase III trials, which is being used to treat anemia secondary to chronic kidney disease. This experience, in addition to becoming a professional highlight, inspired her to pursue a fellowship in Medical Affairs upon graduation from pharmacy school.

Throughout her time at PCP, Dr. Huynh was devoted to serving her community by participating in numerous patient outreach/philanthropic events, annual walks to benefit cancer research, and traveling to Guatemala for a medical mission trip. She is known for her “bubbly” attitude, and always tries to spread optimism wherever she goes.

She self-identifies as a “foodie,” and enjoys exploring new restaurants. In her free time, she loves traveling to New York City to attend exciting pop-up exhibits. Dr. Huynh is excited for this fellowship opportunity and cannot wait for everything this new learning experience will bring.

St. John’s University/Pfizer Pharmaceutical Industry Fellowship—Oncology Global Market Access and Health Economics and Outcomes Research (HEOR)

Si Li

Si Li, Pharm.D., is the 2020–22 St. John’s University/Pfizer Fellow in Oncology Global Market Access and Health Economics and Outcomes Research. She received her Bachelor of Science degree in Chemistry from University of the Sciences in Philadelphia, and her Doctor of Pharmacy Degree from the Massachusetts College of Pharmacy and Health Sciences (MCPHS).

During her time at MCPHS, Dr. Li founded the college’s Drug Information Association student chapter, and additionally served on the executive boards of the American Society of Consultant Pharmacists, Academy of Managed Care Pharmacy, and Future Business Leaders of America student chapters. Dr. Li was also inducted as a member of Phi Lambda Sigma.

Dr. Li loves to explore new places, meet new people, travel, sing, and ride her motorcycle in her free time. She is honored to be the inaugural fellow for this exciting new collaboration between St. John’s University and Pfizer. She is passionate about market access and HEOR, and looks forward to being a part of a diverse team bettering health care and making a global impact for patients.

St. John’s University/Daiichi Sankyo Pharmaceutical Industry Fellowship—Regulatory Affairs/Oncology

Pranav Patel headshot against green background

Pranav Patel, Pharm.D., is the 2019–21 St. John’s University/Daiichi Sankyo Industry Fellow in Regulatory Affairs/Oncology. He earned his Doctor of Pharmacy degree from Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, in Piscataway, NJ.

During his time at Rutgers University, Dr. Patel was actively involved with the American Pharmacists Association, where he was a strong advocate for vaccinations and health policy. Dr. Patel has had experiences as a student by aiding team efforts to bring gene therapies in the orphan disease space to clinical trials and contributing to the submission of Briefing Book materials and helped address pharmacokinetic regulatory hurdles in the Immunology, Hepatology, and Dermatology therapeutic areas. In his free time, Dr. Patel is an avid traveler and an amateur art historian.

St. John’s University/Daiichi Sankyo Pharmaceutical Industry Fellowship—Global Clinical Safety/Oncology

Head shot of Alvi Diggs in front of blue flowers and trees.

Alvi Diggs, Pharm.D., is the 2019–21 St. John’s/Daiichi Sankyo Industry Fellow in Global Clinical Safety/Oncology. She received her Bachelor of Arts degree in Chemistry from North Carolina State University and her Doctor of Pharmacy degree from the University of Maryland, Baltimore.

During her time at the University of Maryland, she completed a pharmaceutical industry rotation, which helped her solidify her decision to pursue a career in the pharmaceutical industry, specifically in clinical safety and pharmacovigilance.

Originally from Liberia, West Africa, Dr. Diggs is an avid traveler and managed to travel to more than six countries during her time in pharmacy school. Dr. Diggs prides herself on being a global citizen and has the long-term goal of impacting health outcomes on a global scale, especially in her home country of Liberia.

She recently spent six weeks in Thailand, where she merged her passion for patient safety with her interest in global health systems. Dr. Diggs is also a voracious reader and loves to experiment in the kitchen. She is looking forward to gaining the skills that she needs to solidify her role in the pharmaceutical industry, as well as being a mentor to other pharmacy students or pharmacists who are interested in this career path.

St. John’s University/Daiichi Sankyo Pharmaceutical Industry Fellowship—Clinical Development/Oncology

Liane Kuo Headshot

Liane Kuo, Pharm.D., is the 2020–22 St. John’s University/Daiichi Sankyo Fellow in Clinical Development/Oncology. She received her Bachelor of Science degree in Molecular Toxicology from the University of California, Berkeley, and her Doctor of Pharmacy degree from the University of Michigan College of Pharmacy. 

Dr. Kuo was actively involved with Michigan’s student chapter of the American Society of Health-System Pharmacists, Academy of Managed Care Pharmacy, and Industry Pharmacists Organization. She completed the ORISE Fellowship at the US Food and Drug Administration’s Office of Clinical Pharmacology, and further pursued her interest in clinical development through rotations within the pharmaceutical industry.

Dr. Kuo looks forward to working on a cross functional team to bring novel cancer therapies to patients around the world. In her free time, Dr. Kuo enjoys volunteering as a crisis counselor, exploring museums, and trying new restaurants.

St. John’s University & American Regent Inc. Pharmaceutical Industry Fellowship
 

PROGRAMS OFFERED
Medical Affairs 

PROGRAM OBJECTIVE
The two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, American Regent. The fellow will have exposure to various departments within American Regent as well as research and teaching opportunities at St. John’s University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry.

Medical Affairs
Pharmacists in the Department of Medical Affairs provide efficient and unbiased medical information concerning the company’s pharmaceutical products to healthcare professionals, consumers, and internal associates. Upon completion of rotation within this department, the fellow will be able to:

Medical Affairs Overview:

  • Develop and utilize strong clinical trial analysis skills to evaluate medical literature, interpret scientific data, and support healthcare professionals and consumers 

  • Create and present educational lectures on products and disease states to internal and external stakeholders 

  • Attend medical/scientific meetings to ensure an in-depth understanding of the latest advances and updated scientific information that will help shape our publication and Investigator Sponsored Study strategies 

  • Work with the Medical Affairs team including, but not limited to: Medical Communications Leads, Medical Science Liaisons, Medical Directors, Medical Writers, and other relevant team members on the development and approval of core clinical material 

  • Manage company expectations while effectively integrating key clinical messages for dissemination to a wide array of audiences 

  • Acquire the medical expertise and experience to thrive in the pharmaceutical industry while complying with FDA and PhRMA regulations 


Medical Science Liaison (MSL) Overview:

  • Establish and maintain working relationships with healthcare professionals 

  • Provide education by creating scientific dialogue around American Regent products and sponsored research 

  • Fellows will have the opportunity to shadow the Medical Science Liaison (MSL) team and attend relevant conferences to deepen their understanding of Medical Affairs in a professional, pharmaceutical industry setting 


COLLEGE OF PHARMACY & HEALTH SCIENCES COMPONENT

The fellow may apply for an affiliate faculty appointment at St. John’s University College of Pharmacy and Health Sciences and will precept entry-level Doctor of Pharmacy students who are assigned to American Regent, Inc. for experiential training. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

  • Formal and informal educational opportunities
  • Collaborative research projects with St. John’s University faculty
  • Development of continuing education courses
  • A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences
  • Graduate degree programs available at the university to further his or her educational development (Master’s or PhD degrees)
  • On-campus teaching opportunities within the Doctor of Pharmacy Program
  • Individual research project(s)
  • Opportunity to participate in a Teaching Certificate Program

CERTIFICATE OF COMPLETION

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and American Regent.

ELIGIBILITY FOR FELLOWSHIP

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

STIPEND AND BENEFITS
The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

LOAN DEFERMENT
Fellows may qualify for a student loan deferment while pursuing the post-graduate fellowship program. Deferment options and repayment terms for education-related loans should be discussed with the lender.


 

St. John's University & Pfizer Inc. Pharmaceutical Industry Fellowship

PROGRAMS OFFERED
Health Economics and Outcomes Research (HEOR)/Market Access

PROGRAM OBJECTIVE
The two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, Pfizer. The fellow will have exposure to various departments within Pfizer as well as research and teaching opportunities at St. John's University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry. 

The objective for the fellowship is to provide hands-on experience in advanced techniques pertaining to HEOR evaluation of cancer pharmaceuticals, in addition to market access experience, to introduce and develop valuable skills in an increasingly important discipline. During this unique two-year fellowship, the fellow will use her/his skills to make positive impact on global patient care. The fellowship spans a variety of payer archetypes and involves establishing strong working relationship with market access, HEOR, commercial, medical and clinical develop functions. 

FELLOWSHIP GOALS AND OBJECTIVES

  • Build and maintain expertise in payer regulations and priorities across major countries
  • Partner with an asset market access lead to execute the market access and pricing strategy for the assigned oncology asset, which includes but is not limited to, executing payer market research, developing payer value proposition and story, market access and pricing negotiations, payer benefit analysis, and contracting solutions
  • Gain proficiency in the field of health economics, outcomes research, and comparative effectiveness research (CER)
  • In collaboration with global HEOR leads, conduct outcomes research evaluations with real world data, develop health economics models to characterize and communicate product budget impact and cost-effectiveness; participate in HEOR projects and gain experience in how a pharmaceutical manufacturer uses clinical, economic and humanistic data to support the development and commercialization of its products
  • Lead the timely development of United States HEOR launch excellence deliverables including economic models and innovative tools to successfully support launch reimbursement and access requirements
  • Manage multiple projects and budgets to target and interact with vendors to execute projects
  • Determine appropriate action, execution, tracking and monitoring of projects
  • Attend professional meetings, as well as internal business meetings, with travel, attendance, and associated cost reimbursed dependent on active research dissemination and business objectives and need

COLLEGE OF PHARMACY & HEALTH SCIENCES COMPONENT

The fellow may apply for an affiliate faculty appointment at St. John's University College of Pharmacy and Health Sciences and will precept entry-level Doctor of Pharmacy students who are assigned to American Regent, Inc. for experiential training. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

  • Formal and informal educational opportunities
  • Collaborative research projects with St. John's University faculty
  • Development of continuing education courses
  • A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences 
  • Graduate degree programs available at the university to further his or her educational development (Master's or PhD degrees)
  • On-campus teaching opportunities within the Doctor of Pharmacy Program
  • Individual research project(s)
  • Opportunity to participate in a Teaching Certificate Program

CERTIFICATE OF COMPLETION

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and American Regent.

ELIGIBILITY FOR FELLOWSHIP

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

STIPEND AND BENEFITS
The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

LOAN DEFERMENT
Fellows may qualify for a student loan deferment while pursuing the post-graduate fellowship program. Deferment options and repayment terms for education-related loans should be discussed with the lender.

\